Current Protein & Peptide Science

Wenzheng Bao received his Ph.D in computer science from Tongji University in 2018. He received the master degree in computer science from the University of Jinan in 2015. He currently works for school of information and electrical engineering, Xuzhou University of Technology, Xuzhou, China. His research interests include bioinformatics, machine learning, computational biology and proteomics.

Dr Martiniano Bello Ramírez obtained BSc. Biological Pharmaceutical Chemistry, from the University of Veracruz (2003), MSc. Biochemical Sciences, National Autonomous University of Mexico (2006), and Ph. D. Biochemical Sciences, National Autonomous University of Mexico (2010). Currently, he is a Research Professor at the Superior School of Medicine of National Polytechnic Institute of Mexico. He has published more than 50 articles in well-reputed journals. Besides, he is a reviewer of many journals such as European Journal of Medical Chemistry, Pharmaceuticals, Journal of Molecular Modeling, PlosOne, Plos Computational Biology, Proteins: Structure, Function, and Bioinformatics, Molecular BioSystems, Physical Chemistry Chemical Physics, Open Chemistry, Anti-Cancer Agents in Medicinal Chemistry and many more.

Dr. Mehedi is a bioinformatics and statistical scientist. He is currently a postdoctoral fellow at the Tulane University, USA. Before his current position, he worked at the Japan Society for the Promotion of Science (JSPS) international PD fellow in the Kyushu Institute of Technology, Japan. He also worked as a researcher at the Chinese University of Hong Kong. He received his PhD degree in bioinformatics from the China Agricultural University, Beijing, in 2016. His main research interests include protein structure prediction, machine learning, data mining, computational biology, and functional genomics.

Dr. Ghulam Md Ashraf currently working as Associate Professor at King Fahd Medical Research Center, King Abdulaziz University, Saudi Arabia. He received his PhD in Biochemistry from Aligarh Muslim University (India) in 2010. Dr. Ashraf has been involved in 14 research projects funded by various agencies of Saudi Arabia, and is a member of renowned professional associations and organizations. He has published 239 articles (total citations: 3301 h-index: 27, i10-index: 89) in journals and books of international repute. Dr. Ashraf is also involved in editorial capacity in many reputed journals, like PLOS one, Scientific Reports, Frontiers in Neuroscience, Current Proteins and Peptides, Journal of Proteomics, to mention a few. Dr. Ashraf’s prime field of research is neurology, currently focusing on understanding the molecular and behavioral mechanism of effects of anti-diabetic drugs in pyschotic and dementia conditions. His lab is currently investigating the effect of anti-diabetic drugs in effective reversal of anti-psychotic drugs induced weight gain in psychosis conditions in Wistar rats. Dr. Ashraf’s lab is also investigating the effect of anti-diabetic drugs in animal models of psychosis and Alzheimer’s disease.

Dr. Anket Sharma is currently working as post-doctoral scientist at State Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, China. Before joining as post- doctoral scientist, he worked as assistant professor at DAV University, Jalandhar, India. He completed his M.Phil. and Ph.D. from Guru Nanak Dev University, Amritsar, India. He was also a DST-INSPIRE Fellow from Department of Science & Technology, Government of India. He has authored 67 articles in journals and 14 chapters in books of international repute.

Professor Hubing Shi received his Ph.D. in Biochemistry and Molecular Biology from the Tsinghua University in 2007 and continued postdoctoral research at the University of California at Los Angeles from 2008-2015. He joined the State Key Laboratory of Biotherapy as professor in China in 2015. His research interests focus on discovery of the acquired resistance mechanisms in targeted therapy and development of novel combinatorial regimens with state-of-the-art treatment in clinics.

Zhaoliang Su has been appointed as a Professor at the Jiangsu University, China. He is currently an Executive Director of International Genome Center, Jiangsu University and focuses on the potential mechanisms of inflammatory disorders, especially, cardiac inflammatory injury, inflammatory resolution and cardiac functional remodeling as well as cancer immune escape.

Dr. Timothy Veenstra received his PhD in biochemistry from the University of Windsor in Canada followed by completion of a post-doctoral fellowship at the Mayo Clinic in Rochester, Minnesota. It was at the Mayo Clinic that he recognized the value of applying mass spectrometry (MS) to biomedical research. He has spent most of his career in research, utilizing MS in the fields of oncology and neurology to identify biomarkers for disease detection as well as identifying protein interactions key to disease progression. He has co-authored almost 400 peer-reviewed manuscripts and is the author of the book “Proteomic Applications in Cancer Detection and Discovery”.

Dr. Wei Wang is a Professor at the Henan Agricultural University (HAU) and a Principal Investigator of the State Laboratory of Wheat and Maize Crop Science, China. He received a PhD from the Institute of Botany, Chinese Academy of Sciences in 1995. He did his Postdoctoral studies at CSIC (Spain, 1999-2001) and University of Siena (2002-2006), where he began his work on crop genomic and proteomic works. In 2006, he moved to HAU, where he was promoted to Full Professor and then distinguished Professor in Henan province. His research focuses on maize omics and improvement. Besides, he is a member of the editorial board at Frontiers in Plant Science (Associate Editor), PLOS ONE (Academic Editor), and Acta Physiologiae Plantarum (Associate Editor).